ONCOLYTICS BIOTECH INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ONCY

organization

SIC: 2834

SEC Insider

$363K

28 transactions

Summary

ONCOLYTICS BIOTECH INC (ONCY) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $363KSales: —14 insiders

Date	Insider	Type	Value
2026-02-12	Andrews Patricia S	Buy	$30K
2026-02-12	Brown Deborah Margaret	Buy	$21K
2026-03-11	Parsons James T.	Buy	$10K
2026-02-12	Heineman Thomas Charles(Chief Medical Officer)	Buy	$10K
2026-02-12	Hagerman Allison(VP, Product Development)	Buy	$8K
2026-03-12	Kelly Jared(Chief Executive Officer)	Buy	$5K
2026-06-01	Heineman Thomas Charles(Chief Medical Officer)	A	$0
2026-06-01	Hagerman Allison(Chief Technology Officer)	A	$0
2026-06-01	Seizinger Bernd R.	A	$0
2026-06-01	Andrews Patricia S	A	$0
2026-06-01	Kelly Jared(Chief Executive Officer)	A	$0
2026-06-01	Aromando Andrew(Chief Business Officer)	A	$0
2026-06-01	Parsons James T.	A	$0
2026-06-01	Look Kirk(Chief Financial Officer)	A	$0
2026-06-01	Holtham Angela	A	$0
2026-06-01	Pisano Wayne	A	$0
2026-06-01	RIGBY JONATHAN	A	$0
2026-06-01	Brown Deborah Margaret	A	$0
2026-06-01	Glover Stephen C.	A	$0
2026-06-01	McAdory John Bearden(Chief Operating Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ONCOLYTICS BIOTECH INC — Contributions, Lobbying & Contracts | Poliscope